Additionally, central administration of low STZ doses triggers an insulin-resistance brain state that produces similar neuropathology and biochemical alterations observed during AD, enabling the pathophysiology of sporadic Alzheimer’s disease (sAD) to be further comprehended. Here, INS is linked to Alzheimer disease.